These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mifepristone (RU486): a review. Mahajan DK; London SN Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681 [TBL] [Abstract][Full Text] [Related]
3. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Ashok PW; Flett GM; Templeton A Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062 [TBL] [Abstract][Full Text] [Related]
4. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079 [TBL] [Abstract][Full Text] [Related]
5. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Guengant JP; Bangou J; Elul B; Ellertson C Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161 [TBL] [Abstract][Full Text] [Related]
6. Mifepristone. DeHart RM; Morehead MS Ann Pharmacother; 2001 Jun; 35(6):707-19. PubMed ID: 11408990 [TBL] [Abstract][Full Text] [Related]
7. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486). el-Refaey H; Hinshaw K; Templeton A Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Baird DT; Sukcharoen N; Thong KJ Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of mifepristone. Heikinheimo O Clin Pharmacokinet; 1997 Jul; 33(1):7-17. PubMed ID: 9250420 [TBL] [Abstract][Full Text] [Related]
13. Mifepristone (RU 486) in the United States. What does the future hold? Rosenfield A N Engl J Med; 1993 May; 328(21):1560-1. PubMed ID: 8479494 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. Webb AM; Russell J; Elstein M BMJ; 1992 Oct; 305(6859):927-31. PubMed ID: 1458074 [TBL] [Abstract][Full Text] [Related]
15. Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties. Sun Y; Fang M; Davies H; Hu Z Gynecol Endocrinol; 2014 Mar; 30(3):169-73. PubMed ID: 24205903 [TBL] [Abstract][Full Text] [Related]